Adjustment of a Cellular Based Methodology to Predict Response to Melphalan - Oxaliplatin in Breast and Colon Cancer

  • Published:19. May 2011
  • Dashboard:33rd Conference EEBE – Adjustment of a Cellular Based Methodology to Predict Response to Melphalan - Oxaliplatin in Breast and Colon Cancer
  • Authors:Apostolou P., Toloudi M., Chatziioannou M., Papasotiriou I.

Read article

Find out more about the scientific basis of RGCC tests

More information